Description
Dyronib™ is a quality assured generic of Sprycel® used to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in adults and children. It is also used to treat Ph+ CML and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in adults with resistance or intolerance to prior therapy including imatinib. It’s also indicated for the treatment of pediatric patients 1 year of age and older with newly diagnosed Ph+ ALL in combination with chemotherapy. It’s produced in a US FDA approved factory in India.
Bottle Size : 60 Tablets
Active Ingredients : Dasatinib 70 MG
Produced by Hetero Drugs Ltd®